Skip to main content

Month: March 2025

XBP Europe Holdings, Inc. Signs Exclusive Non-Binding Letter of Intent to Acquire Exela Technologies BPA, LLC

Merger would expand XBP Europe into a $1 billion revenue business SANTA MONICA, Calif., March 04, 2025 (GLOBE NEWSWIRE) — XBP Europe Holdings, Inc. (“XBP Europe”) (Nasdaq: XBP), a pan-European integrator of bills, payments, and related solutions and services, today announced that it has entered into an exclusive, non-binding letter of intent with Exela Technologies, Inc. to acquire Exela Technologies BPA, LLC (“BPA”), a leading provider of business process automation solutions. The closing of the acquisition will be subject to BPA completing a corporate reorganization which is expected to create a sustainable capital structure with a substantially deleveraged balance sheet. If completed, the acquisition will expand XBP Europe’s revenue to more than $1 billion from $145 million on a pro forma basis for the twelve months ending September...

Continue reading

ACELYRIN Determines Unsolicited Indication of Interest From Concentra Biosciences Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis Merger

All-Stock Transaction with Alumis Maximizes Long-Term Value for ACELYRIN Stockholders LOS ANGELES, March 04, 2025 (GLOBE NEWSWIRE) — ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that, after due consideration in consultation with its independent financial and legal advisors, its Board of Directors determined that the unsolicited indication of interest from Concentra Biosciences, LLC, of which Tang Capital Partners, LP is the controlling shareholder, is not reasonably expected to result in a superior proposal to the planned merger with Alumis Inc. (Nasdaq: ALMS). The ACELYRIN Board of Directors is confident that the all-stock transaction with Alumis maximizes long-term value for ACELYRIN stockholders...

Continue reading

DraftKings Announces Close of $600 Million Upsized Term Loan B Facility

BOSTON, March 04, 2025 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (the “Company” or “DraftKings”) today announced that it has successfully closed on its senior secured term loan B credit facility in an aggregate principal amount of $600 million (the “Term Loan B”). The size of the Term Loan B was increased from the previously announced $500 million aggregate principal amount due to strong demand. The Term Loan B will mature in March 2032 and has an interest rate equal to the Secured Overnight Financing Rate (SOFR) plus 1.75% per annum. The Term Loan B was offered at 99.50% of par and is required to be repaid at 1.00% of its aggregate principal amount per annum. DraftKings will utilize the net proceeds of the Term Loan B for general corporate purposes. About DraftKings DraftKings Inc. is a digital sports entertainment and...

Continue reading

Alset Inc. Announces Engagement with the Robotics Sector

BETHESDA, MD, March 04, 2025 (GLOBE NEWSWIRE) — Alset Inc. (NASDAQ: AEI) (the “Company”), a diversified company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities and consumer products with operations in the United States, Singapore, Hong Kong and South Korea, is pleased to announce its strategic foray into the rapidly growing robotics sector, through a stake in Alset Robot Inc. (“Alset Robot”). Alset Robot is majority owned by the Company and certain subsidiaries of the Company, including the Company’s Singapore-based subsidiary Alset International Limited. The Company has set its sights on becoming a force in the robotics industry by delivering service solutions and offering a diverse portfolio of products...

Continue reading

SEALSQ Issues CEO Letter to Shareholders

Geneva, Switzerland, March 04, 2025 (GLOBE NEWSWIRE) — SEALSQ Issues CEO Letter to Shareholders Geneva, Switzerland, March 4, 2025 — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today issues a CEO Letter to Shareholders. Dear Shareholders, We are pleased to share an update on SEALSQ’s financial and strategic progress, highlighting significant advancements that strengthened its balance sheet and positioned the Company for sustained growth. Upcoming Release of SEALSQ’s 2024 Audited Financial ResultsSEALSQ will release its audited 2024 financial results on or before March 21, 2025. This will provide shareholders with a comprehensive overview of our financial performance,...

Continue reading

Data443 Completes Operational Expense Rationalization

RESEARCH TRIANGLE PARK, N.C., March 04, 2025 (GLOBE NEWSWIRE) — Data443 Risk Mitigation, Inc. (OTCPK: ATDS) (“Data443” or the “Company”), an AI data security and privacy software company for “All Things Data Security,” today announced the completion of major operational expense rationalizations yielding immediate and long-term financial benefits. $3.1 Million in Annual Cost Savings Achieved “As part of our march toward profitability and operational efficiencies across all acquisitions, we have successfully eliminated over $3.1 million in annualized operational expenses from our current operations,” stated Jason Remillard, CEO of Data443. This cost optimization initiative follows the Company’s recent expansion in the AI sector, including an acquisition focused on email categorization and classification...

Continue reading

Cibus’ Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola

Initial bioassay data for Cibus’ third mode of action for white mold (Sclerotinia) resistance trait in canola shows promising results in controlled environment assessment Cibus’ white mold resistance traits are expected to help preserve crop yields and reduce fungicide usage for farmers SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that controlled environment testing of its third mode of action (MOA) for its Sclerotinia resistance trait in Canola demonstrated enhanced resistance. The core of Cibus’ gene editing technology is its Rapid Trait Development System™ or RTDS®. It is a system of proprietary technologies that integrates crop specific cell biology...

Continue reading

Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders

Leiden, the Netherlands, March 4, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda. Shareholders approved the appointment of Mr. Fabrice Chouraqui as Executive Director and Chief Executive Officer for a term of four years. As a result, Mr. Chouraqui succeeds Mr. Sijmen de Vries with immediate effect. To ensure a smooth hand-over of tasks and responsibilities, Mr. de Vries will remain a strategic advisor to the new CEO until December 31, 2025. In addition, shareholders also approved the proposal to approve certain components of the remuneration package of Mr. Chouraqui in his capacity as Executive Director and Chief Executive Officer. A recording of the webcast, presentation...

Continue reading

Hollywood Star Cuts Brings the Movie Star Experience to the UK!

LAS VEGAS, March 04, 2025 (GLOBE NEWSWIRE) — All American Gold Corp. (OTC: AAGC) is elated to update the public about Hollywood Star Cuts’ aggressive growth into the European market. On February 23rd, 2025, AAGC and Hollywood Star Cuts formally entered an agreement with a franchise group from England to develop the Hollywood Star Cuts model throughout the United Kingdom. In late January 2025, Hollywood Star Cuts was approached by a team of successful entrepreneurs based in London England. This particular group had been instrumental in importing and developing Fast Food brands from America, Breakfast brands from Canada as well as others. Hollywood Star Cuts and the English development group utilized the previous month to establish an agreement that will ensure their success while increasing revenues and worldwide exposure for Hollywood...

Continue reading

49-Year Business Graphics 3 Sold to New Minuteman Press Franchise Owner Tyler Griffith in Coldwater, MI

Minuteman Press Franchise Coldwater, MINew Minuteman Press Franchise Owner Tyler Griffith (left) has purchased 49-year business Graphics 3 from Mike Iveson (right). Moving forward, the business is operating as Minuteman Press in Coldwater, MI.COLDWATER, Mich., March 04, 2025 (GLOBE NEWSWIRE) — Graphics 3, a second-generation printing business owned by Iveson family for 49 years, has been sold by retiring owner Mike Iveson to new Minuteman Press franchise owner Tyler Griffith. Moving forward, the business will operate as Minuteman Press in Coldwater and remains located at 205 W. Garfield Avenue, Coldwater, MI 49036. On selling the business, Mike shares, “Tyler Griffith has been great to work with, allowing me to decompress from owner to bystander. The transition has been even better than I expected and everything has worked...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.